Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 · kind B2 · utility
18Cited by
572References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 9, 2018 |
| Grant date | Nov 12, 2019 |
| Priority date | — |
| Expiry date | Feb 9, 2038 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K47/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
In one aspect, pharmaceutical compositions and methods for the treatment of vulvovaginal atrophy (VVA) are provided. In one embodiment, the method comprises digitally inserting into the lower third of the vagina of a subject having VVA a soft gelatin capsule containing a liquid pharmaceutical composition.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.